A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension (Q80413342)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Strasser RH

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Puig JG

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Farsang C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Croket M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Li J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

van Ingen H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

31 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

780-787

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17541390%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002220

31 December 2019

exact match

0 references

cites work

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Continuation of initial antihypertensive medication after 1 year of therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Calcium channel blocker-related periperal edema: can it be resolved?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

The preparation, purification, and amino acid sequence of a polypeptide renin substrate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Structure-based design of aliskiren, a novel orally effective renin inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021

Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002220

7 January 2021